Purchases and Sales Made in Q1 2022 in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during Q1 2022. The information is specifically focused on institutions that hold shares of BIOCRYST PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-357K- 30.95% |
$4.12M - $7.05M
|
796K
$6.02M
|
|
|
May 16, 2022
Q1 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-381K- 17.7% |
$4.4M - $7.53M
|
1.77M
$13.4M
|
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-390K- 73.13% |
$4.5M - $7.7M
|
143K
$1.08M
|
|
|
Jun 10, 2022
Q1 2022
|
J.W. Cole Advisors, Inc.
|
SELL
|
- |
-467K- 93.81% |
$5.4M - $9.23M
|
30.8K
$233K
|
|
|
May 16, 2022
Q1 2022
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-566K- 81.62% |
$6.55M - $11.2M
|
128K
$965K
|
|
|
May 16, 2022
Q1 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-613K- 54.16% |
$7.09M - $12.1M
|
519K
$3.93M
|
|
|
May 16, 2022
Q1 2022
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-661K- 58.48% |
$7.64M - $13.1M
|
469K
$3.55M
|
|
|
May 16, 2022
Q1 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-674K- 39.98% |
$7.79M - $13.3M
|
1.01M
$7.66M
|
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-685K- 4.64% |
$7.92M - $13.5M
|
14.1M
$107M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-718KClosed |
$8.3M - $14.2M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-756K- 37.89% |
$8.74M - $14.9M
|
1.24M
$9.38M
|
|
|
May 16, 2022
Q1 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-786K- 9.53% |
$9.09M - $15.5M
|
7.46M
$56.5M
|
|
|
May 16, 2022
Q1 2022
|
Bain Capital Public Equity Management Ii, LLC
Boston, MA |
SELL
|
- |
-907K- 63.56% |
$10.5M - $17.9M
|
520K
$3.94M
|
|
|
May 16, 2022
Q1 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-1.02M- 83.72% |
$11.8M - $20.2M
|
199K
$1.51M
|
|
|
May 16, 2022
Q1 2022
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-1.51MClosed |
$17.5M - $29.8M
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Health Cor Management, L.P.
New York, NY |
SELL
|
- |
-2.15M- 90.39% |
$24.8M - $42.5M
|
228K
$1.73M
|
|
|
May 16, 2022
Q1 2022
|
Sarissa Capital Management LP
Greenwich, CT |
SELL
|
- |
-2.65M- 65.57% |
$30.6M - $52.3M
|
1.39M
$10.5M
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.67M- 83.77% |
$42.4M - $72.4M
|
710K
$5.38M
|